{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T08:58:34Z","timestamp":1789894714213,"version":"4.0.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T00:00:00Z","timestamp":1527033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T00:00:00Z","timestamp":1527033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Dendritic cells (DCs) have a key role in orchestrating immune responses and are considered important targets for immunotherapy against cancer. In order to develop effective cancer vaccines, detailed knowledge of the micromilieu in cancer lesions is warranted. In this study, flow cytometry and human transcriptome arrays were used to characterize subsets of DCs in head and neck squamous cell tonsillar cancer and compare them to their counterparts in benign tonsils to evaluate subset-selective biomarkers associated with tonsillar cancer. We describe, for the first time, four subsets of DCs in tonsillar cancer: CD123<jats:sup>+<\/jats:sup> plasmacytoid DCs (pDC), CD1c<jats:sup>+<\/jats:sup>, CD141<jats:sup>+<\/jats:sup>, and CD1c<jats:sup>\u2212<\/jats:sup>CD141<jats:sup>\u2212<\/jats:sup> myeloid DCs (mDC). An increased frequency of DCs and an elevated mDC\/pDC ratio were shown in malignant compared to benign tonsillar tissue. The microarray data demonstrates characteristics specific for tonsil cancer DC subsets, including expression of immunosuppressive molecules and lower expression levels of genes involved in development of effector immune responses in DCs in malignant tonsillar tissue, compared to their counterparts in benign tonsillar tissue. Finally, we present target candidates selectively expressed by different DC subsets in malignant tonsils and confirm expression of CD206\/MRC1 and CD207\/Langerin on CD1c<jats:sup>+<\/jats:sup> DCs at protein level. This study descibes DC characteristics in the context of head and neck cancer and add valuable steps towards future DC-based therapies against tonsillar cancer.<\/jats:p>","DOI":"10.1038\/s41598-018-26193-y","type":"journal-article","created":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T08:59:32Z","timestamp":1526547572000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Profiling dendritic cell subsets in head and neck squamous cell tonsillar cancer and benign tonsils"],"prefix":"10.1038","volume":"8","author":[{"given":"Milad","family":"Abolhalaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Askmyr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina Alexandra","family":"Sakellariou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Greiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Lindstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,23]]},"reference":[{"key":"26193_CR1","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1038\/sj.bjc.6601373","volume":"89","author":"F Lemaire","year":"2003","unstructured":"Lemaire, F. et al. Differential expression profiling of head and neck squamous cell carcinoma (HNSCC). Br J Cancer 89, 1940\u20131949, https:\/\/doi.org\/10.1038\/sj.bjc.6601373 (2003).","journal-title":"Br J Cancer"},{"key":"26193_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc2982","volume":"11","author":"CR Leemans","year":"2011","unstructured":"Leemans, C. R., Braakhuis, B. J. & Brakenhoff, R. H. The molecular biology of head and neck cancer. Nat Rev Cancer 11, 9\u201322, https:\/\/doi.org\/10.1038\/nrc2982 (2011).","journal-title":"Nat Rev Cancer"},{"key":"26193_CR3","doi-asserted-by":"publisher","unstructured":"Bann, D. V., Deschler, D. G. & Goyal, N. Novel Immunotherapeutic Approaches for Head and Neck Squamous Cell Carcinoma. Cancers (Basel) 8, https:\/\/doi.org\/10.3390\/cancers8100087 (2016).","DOI":"10.3390\/cancers8100087"},{"key":"26193_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12026-013-8462-3","volume":"57","author":"ME Freiser","year":"2013","unstructured":"Freiser, M. E., Serafini, P. & Weed, D. T. The immune system and head and neck squamous cell carcinoma: from carcinogenesis to new therapeutic opportunities. Immunol Res 57, 52\u201369, https:\/\/doi.org\/10.1007\/s12026-013-8462-3 (2013).","journal-title":"Immunol Res"},{"key":"26193_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/978-1-4614-3146-6_15","volume":"746","author":"R Yamanaka","year":"2012","unstructured":"Yamanaka, R. & Kajiwara, K. Dendritic cell vaccines. Adv Exp Med Biol 746, 187\u2013200, https:\/\/doi.org\/10.1007\/978-1-4614-3146-6_15 (2012).","journal-title":"Adv Exp Med Biol"},{"key":"26193_CR6","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrc3258","volume":"12","author":"K Palucka","year":"2012","unstructured":"Palucka, K. & Banchereau, J. Cancer immunotherapy via dendritic cells. Nat Rev Cancer 12, 265\u2013277, https:\/\/doi.org\/10.1038\/nrc3258 (2012).","journal-title":"Nat Rev Cancer"},{"key":"26193_CR7","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nature06175","volume":"449","author":"RM Steinman","year":"2007","unstructured":"Steinman, R. M. & Banchereau, J. Taking dendritic cells into medicine. Nature 449, 419\u2013426, https:\/\/doi.org\/10.1038\/nature06175 (2007).","journal-title":"Nature"},{"key":"26193_CR8","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.4049\/jimmunol.1402535","volume":"194","author":"A Reuter","year":"2015","unstructured":"Reuter, A. et al. Criteria for Dendritic Cell Receptor Selection for Efficient Antibody-Targeted Vaccination. Journal of Immunology 194, 2696\u20132705, https:\/\/doi.org\/10.4049\/jimmunol.1402535 (2015).","journal-title":"Journal of Immunology"},{"key":"26193_CR9","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.4049\/jimmunol.180.6.3647","volume":"180","author":"J Idoyaga","year":"2008","unstructured":"Idoyaga, J. et al. Cutting edge: langerin\/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo. J Immunol 180, 3647\u20133650 (2008).","journal-title":"J Immunol"},{"key":"26193_CR10","doi-asserted-by":"publisher","first-page":"5828","DOI":"10.4049\/jimmunol.171.11.5828","volume":"171","author":"S Watanabe","year":"2003","unstructured":"Watanabe, S. et al. The duration of signaling through CD40 directs biological ability of dendritic cells to induce antitumor immunity. Journal of Immunology 171, 5828\u20135836 (2003).","journal-title":"Journal of Immunology"},{"key":"26193_CR11","doi-asserted-by":"publisher","first-page":"6783","DOI":"10.4049\/jimmunol.0901296","volume":"185","author":"SC Jones","year":"2010","unstructured":"Jones, S. C., Brahmakshatriya, V., Huston, G., Dibble, J. & Swain, S. L. TLR-Activated Dendritic Cells Enhance the Response of Aged Naive CD4 T Cells via an IL-6-Dependent Mechanism. Journal of Immunology 185, 6783\u20136794, https:\/\/doi.org\/10.4049\/jimmunol.0901296 (2010).","journal-title":"Journal of Immunology"},{"key":"26193_CR12","doi-asserted-by":"publisher","first-page":"e52875","DOI":"10.1371\/journal.pone.0052875","volume":"8","author":"K Lundberg","year":"2013","unstructured":"Lundberg, K. et al. Transcriptional profiling of human dendritic cell populations and models\u2013unique profiles of in vitro dendritic cells and implications on functionality and applicability. PLoS One 8, e52875, https:\/\/doi.org\/10.1371\/journal.pone.0052875 (2013).","journal-title":"PLoS One"},{"key":"26193_CR13","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1016\/j.celrep.2016.08.023","volume":"16","author":"K Worah","year":"2016","unstructured":"Worah, K. et al. Proteomics of Human Dendritic Cell Subsets Reveals Subset-Specific Surface Markers and Differential Inflammasome Function. Cell Reports 16, 2953\u20132966, https:\/\/doi.org\/10.1016\/j.celrep.2016.08.023 (2016).","journal-title":"Cell Reports"},{"key":"26193_CR14","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.4049\/jimmunol.175.8.4839","volume":"175","author":"M Lindstedt","year":"2005","unstructured":"Lindstedt, M., Lundberg, K. & Borrebaeck, C. A. Gene family clustering identifies functionally associated subsets of human in vivo blood and tonsillar dendritic cells. J Immunol 175, 4839\u20134846 (2005).","journal-title":"J Immunol"},{"key":"26193_CR15","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.4049\/jimmunol.1401903","volume":"194","author":"E Hartung","year":"2015","unstructured":"Hartung, E. et al. Induction of potent CD8 T cell cytotoxicity by specific targeting of antigen to cross-presenting dendritic cells in vivo via murine or human XCR1. J Immunol 194, 1069\u20131079, https:\/\/doi.org\/10.4049\/jimmunol.1401903 (2015).","journal-title":"J Immunol"},{"key":"26193_CR16","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1182\/blood-2013-04-495424","volume":"122","author":"G Nizzoli","year":"2013","unstructured":"Nizzoli, G. et al. Human CD1c\u2009+\u2009dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses. Blood 122, 932\u2013942, https:\/\/doi.org\/10.1182\/blood-2013-04-495424 (2013).","journal-title":"Blood"},{"key":"26193_CR17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1182\/blood-2012-06-435644","volume":"121","author":"J Tel","year":"2013","unstructured":"Tel, J. et al. Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8(+) T cells despite lower Ag uptake than myeloid dendritic cell subsets. Blood 121, 459\u2013467, https:\/\/doi.org\/10.1182\/blood-2012-06-435644 (2013).","journal-title":"Blood"},{"key":"26193_CR18","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1172\/JCI33583","volume":"118","author":"C Liu","year":"2008","unstructured":"Liu, C. et al. Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice. J Clin Invest 118, 1165\u20131175, https:\/\/doi.org\/10.1172\/JCI33583 (2008).","journal-title":"J Clin Invest"},{"key":"26193_CR19","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.4049\/jimmunol.1303259","volume":"192","author":"CP Chappell","year":"2014","unstructured":"Chappell, C. P. et al. Targeting Antigens through Blood Dendritic Cell Antigen 2 on Plasmacytoid Dendritic Cells Promotes Immunologic Tolerance. Journal of Immunology 192, 5789\u20135801, https:\/\/doi.org\/10.4049\/jimmunol.1303259 (2014).","journal-title":"Journal of Immunology"},{"key":"26193_CR20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.humimm.2009.02.003","volume":"70","author":"K Steinbrink","year":"2009","unstructured":"Steinbrink, K., Mahnke, K., Grabbe, S., Enk, A. H. & Jonuleit, H. Myeloid dendritic cell: From sentinel of immunity to key player of peripheral tolerance? Hum Immunol 70, 289\u2013293, https:\/\/doi.org\/10.1016\/j.humimm.2009.02.003 (2009).","journal-title":"Hum Immunol"},{"key":"26193_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/imm.12117","volume":"140","author":"M Collin","year":"2013","unstructured":"Collin, M., McGovern, N. & Haniffa, M. Human dendritic cell subsets. Immunology 140, 22\u201330, https:\/\/doi.org\/10.1111\/imm.12117 (2013).","journal-title":"Immunology"},{"key":"26193_CR22","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.immuni.2008.06.017","volume":"29","author":"A Goubier","year":"2008","unstructured":"Goubier, A. et al. Plasmacytoid dendritic cells mediate oral tolerance. Immunity 29, 464\u2013475, https:\/\/doi.org\/10.1016\/j.immuni.2008.06.017 (2008).","journal-title":"Immunity"},{"key":"26193_CR23","doi-asserted-by":"publisher","unstructured":"Villani, A. C. et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science 356, https:\/\/doi.org\/10.1126\/science.aah4573 (2017).","DOI":"10.1126\/science.aah4573"},{"key":"26193_CR24","doi-asserted-by":"publisher","first-page":"5571","DOI":"10.4049\/jimmunol.0803494","volume":"184","author":"F Jimenez","year":"2010","unstructured":"Jimenez, F. et al. CCR2 plays a critical role in dendritic cell maturation: possible role of CCL2 and NF-kappa B. J Immunol 184, 5571\u20135581, https:\/\/doi.org\/10.4049\/jimmunol.0803494 (2010).","journal-title":"J Immunol"},{"key":"26193_CR25","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.yexcr.2010.10.023","volume":"317","author":"T Yoshimura","year":"2011","unstructured":"Yoshimura, T. & Oppenheim, J. J. Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties. Exp Cell Res 317, 674\u2013684, https:\/\/doi.org\/10.1016\/j.yexcr.2010.10.023 (2011).","journal-title":"Exp Cell Res"},{"key":"26193_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1089\/gtmb.2017.0125","volume":"22","author":"F Chen","year":"2018","unstructured":"Chen, F. et al. Expression of the Chemokine Receptor CXCR3 Correlates with Dendritic Cell Recruitment and Prognosis in Gastric Cancer. Genet Test Mol Biomarkers 22, 35\u201342, https:\/\/doi.org\/10.1089\/gtmb.2017.0125 (2018).","journal-title":"Genet Test Mol Biomarkers"},{"key":"26193_CR27","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.immuni.2016.10.008","volume":"45","author":"A Jones","year":"2016","unstructured":"Jones, A. et al. Immunomodulatory Functions of BTLA and HVEM Govern Induction of Extrathymic Regulatory T Cells and Tolerance by Dendritic Cells. Immunity 45, 1066\u20131077, https:\/\/doi.org\/10.1016\/j.immuni.2016.10.008 (2016).","journal-title":"Immunity"},{"key":"26193_CR28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/eji.200324550","volume":"34","author":"BG Beinhauer","year":"2004","unstructured":"Beinhauer, B. G. et al. Interleukin 10 regulates cell surface and soluble LIR-2 (CD85d) expression on dendritic cells resulting in T cell hyporesponsiveness in vitro. Eur J Immunol 34, 74\u201380, https:\/\/doi.org\/10.1002\/eji.200324550 (2004).","journal-title":"Eur J Immunol"},{"key":"26193_CR29","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1002\/1521-4141(200011)30:11<3132::AID-IMMU3132>3.0.CO;2-E","volume":"30","author":"A Bouloc","year":"2000","unstructured":"Bouloc, A., Bagot, M., Delaire, S., Bensussan, A. & Boumsell, L. Triggering CD101 molecule on human cutaneous dendritic cells inhibits T cell proliferation via IL-10 production. Eur J Immunol 30, 3132\u20133139, https:\/\/doi.org\/10.1002\/1521-4141(200011)30:11&#60;3132::AID-IMMU3132&#62;3.0.CO;2-E (2000).","journal-title":"Eur J Immunol"},{"key":"26193_CR30","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/j.transproceed.2013.03.015","volume":"45","author":"H Liu","year":"2013","unstructured":"Liu, H. et al. PD-L1 signal on liver dendritic cells is critical for Foxp3(+)CD4(+)CD25(+) Treg and liver tolerance induction in mice. Transplant Proc 45, 1853\u20131855, https:\/\/doi.org\/10.1016\/j.transproceed.2013.03.015 (2013).","journal-title":"Transplant Proc"},{"key":"26193_CR31","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/nm1097","volume":"10","author":"JR Conejo-Garcia","year":"2004","unstructured":"Conejo-Garcia, J. R. et al. Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A. Nat Med 10, 950\u2013958, https:\/\/doi.org\/10.1038\/nm1097 (2004).","journal-title":"Nat Med"},{"key":"26193_CR32","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00262-016-1879-5","volume":"65","author":"N Kheshtchin","year":"2016","unstructured":"Kheshtchin, N. et al. Inhibition of HIF-1alpha enhances anti-tumor effects of dendritic cell-based vaccination in a mouse model of breast cancer. Cancer Immunol Immunother 65, 1159\u20131167, https:\/\/doi.org\/10.1007\/s00262-016-1879-5 (2016).","journal-title":"Cancer Immunol Immunother"},{"key":"26193_CR33","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.biochi.2007.04.018","volume":"89","author":"P Fitzgerald-Bocarsly","year":"2007","unstructured":"Fitzgerald-Bocarsly, P. & Feng, D. The role of type I interferon production by dendritic cells in host defense. Biochimie 89, 843\u2013855, https:\/\/doi.org\/10.1016\/j.biochi.2007.04.018 (2007).","journal-title":"Biochimie"},{"key":"26193_CR34","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1158\/0008-5472.CAN-17-1980","volume":"78","author":"A Cauwels","year":"2018","unstructured":"Cauwels, A. et al. Delivering Type I Interferon to Dendritic Cells Empowers Tumor Eradication and Immune Combination Treatments. Cancer Res 78, 463\u2013474, https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-1980 (2018).","journal-title":"Cancer Res"},{"key":"26193_CR35","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.otohns.2004.03.016","volume":"131","author":"A Sparano","year":"2004","unstructured":"Sparano, A., Lathers, D. M., Achille, N., Petruzzelli, G. J. & Young, M. R. Modulation of Th1 and Th2 cytokine profiles and their association with advanced head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 131, 573\u2013576, https:\/\/doi.org\/10.1016\/j.otohns.2004.03.016 (2004).","journal-title":"Otolaryngol Head Neck Surg"},{"key":"26193_CR36","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.intimp.2008.01.031","volume":"8","author":"GV Hegde","year":"2008","unstructured":"Hegde, G. V., Meyers-Clark, E., Joshi, S. S. & Sanderson, S. D. A conformationally-biased, response-selective agonist of C5a acts as a molecular adjuvant by modulating antigen processing and presentation activities of human dendritic cells. Int Immunopharmacol 8, 819\u2013827, https:\/\/doi.org\/10.1016\/j.intimp.2008.01.031 (2008).","journal-title":"Int Immunopharmacol"},{"key":"26193_CR37","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.1016\/j.vaccine.2012.04.084","volume":"30","author":"CY Hung","year":"2012","unstructured":"Hung, C. Y. et al. An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection. Vaccine 30, 4681\u20134690, https:\/\/doi.org\/10.1016\/j.vaccine.2012.04.084 (2012).","journal-title":"Vaccine"},{"key":"26193_CR38","first-page":"3096","volume":"61","author":"C Menetrier-Caux","year":"2001","unstructured":"Menetrier-Caux, C., Thomachot, M. C., Alberti, L., Montmain, G. & Blay, J. Y. IL-4 prevents the blockade of dendritic cell differentiation induced by tumor cells. Cancer Res 61, 3096\u20133104 (2001).","journal-title":"Cancer Res"},{"key":"26193_CR39","doi-asserted-by":"publisher","first-page":"7194","DOI":"10.4049\/jimmunol.174.11.7194","volume":"174","author":"J Eguchi","year":"2005","unstructured":"Eguchi, J. et al. IL-4-transfected tumor cell vaccines activate tumor-infiltrating dendritic cells and promote type-1 immunity. J Immunol 174, 7194\u20137201 (2005).","journal-title":"J Immunol"},{"key":"26193_CR40","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.4049\/jimmunol.1000808","volume":"186","author":"T Tsuji","year":"2011","unstructured":"Tsuji, T. et al. Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8\u2009+\u2009and CD4\u2009+\u2009T cell responses with broad antigen specificity. J Immunol 186, 1218\u20131227, https:\/\/doi.org\/10.4049\/jimmunol.1000808 (2011).","journal-title":"J Immunol"},{"key":"26193_CR41","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1038\/cti.2016.6","volume":"5","author":"C Macri","year":"2016","unstructured":"Macri, C., Dumont, C., Johnston, A. P. & Mintern, J. D. Targeting dendritic cells: a promising strategy to improve vaccine effectiveness. Clin Transl Immunology 5, e66, https:\/\/doi.org\/10.1038\/cti.2016.6 (2016).","journal-title":"Clin Transl Immunology"},{"key":"26193_CR42","doi-asserted-by":"publisher","first-page":"e1196311","DOI":"10.1080\/2162402X.2016.1196311","volume":"5","author":"E Ladomersky","year":"2016","unstructured":"Ladomersky, E. et al. Improving vaccine efficacy against malignant glioma. Oncoimmunology 5, e1196311, https:\/\/doi.org\/10.1080\/2162402X.2016.1196311 (2016).","journal-title":"Oncoimmunology"},{"key":"26193_CR43","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/jgm.1649","volume":"14","author":"M Tandon","year":"2012","unstructured":"Tandon, M. et al. EphrinA1-EphA2 interaction-mediated apoptosis and FMS-like tyrosine kinase 3 receptor ligand-induced immunotherapy inhibit tumor growth in a breast cancer mouse model. J Gene Med 14, 77\u201389, https:\/\/doi.org\/10.1002\/jgm.1649 (2012).","journal-title":"J Gene Med"},{"key":"26193_CR44","doi-asserted-by":"publisher","first-page":"e1004556","DOI":"10.1371\/journal.ppat.1004556","volume":"10","author":"A Egli","year":"2014","unstructured":"Egli, A. et al. IL-28B is a key regulator of B- and T-cell vaccine responses against influenza. PLoS Pathog 10, e1004556, https:\/\/doi.org\/10.1371\/journal.ppat.1004556 (2014).","journal-title":"PLoS Pathog"},{"key":"26193_CR45","doi-asserted-by":"publisher","first-page":"e87102","DOI":"10.1172\/jci.insight.87102","volume":"1","author":"KM Tullett","year":"2016","unstructured":"Tullett, K. M. et al. Targeting CLEC9A delivers antigen to human CD141\u2009+\u2009DC for CD4\u2009+\u2009and CD8\u2009+\u2009T cell recognition. JCI Insight 1, e87102, https:\/\/doi.org\/10.1172\/jci.insight.87102 (2016).","journal-title":"JCI Insight"},{"key":"26193_CR46","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.4049\/jimmunol.172.5.2845","volume":"172","author":"V Ramakrishna","year":"2004","unstructured":"Ramakrishna, V. et al. Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules. J Immunol 172, 2845\u20132852 (2004).","journal-title":"J Immunol"},{"key":"26193_CR47","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1182\/blood-2005-01-0318","volume":"106","author":"PJ Tacken","year":"2005","unstructured":"Tacken, P. J. et al. Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody. Blood 106, 1278\u20131285, https:\/\/doi.org\/10.1182\/blood-2005-01-0318 (2005).","journal-title":"Blood"},{"key":"26193_CR48","doi-asserted-by":"publisher","unstructured":"Klauber, T. C. et al. Delivery of TLR7 agonist to monocytes and dendritic cells by DCIR targeted liposomes induces robust production of anti-cancer cytokines. Acta Biomater, https:\/\/doi.org\/10.1016\/j.actbio.2017.01.072 (2017).","DOI":"10.1016\/j.actbio.2017.01.072"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26193-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26193-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26193-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T05:47:47Z","timestamp":1671601667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26193-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,23]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["26193"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-26193-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,23]]},"assertion":[{"value":"24 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8030"}}